Most Farxiga Diabetic Ketoacidosis Claims Dismissed In Federal Case
GREENVILLE, Miss. — A Mississippi federal judge on Feb. 22 dismissed without prejudice most of a plaintiff’s Farxiga diabetic ketoacidosis (DKA) claims (Kamilah Young v. Bristol-Myers Squibb Company, et al., No....To view the full article, register now.
Already a subscriber? Click here to view full article